Indication

CLN3

1 clinical trial

1 product

Clinical trial

Phase I/IIa Gene Transfer Clinical Trial for Juvenile Neuronal Ceroid Lipofuscinosis, Delivering the CLN3 Gene by Self-Complementary AAV9

Status: Active (not recruiting), Estimated PCD: 2024-09-30

Product